Generated by AI
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that focuses on developing and licensing technologies and assets that support the discovery and development of medicines. Ligand Pharmaceuticals Incorporated operates a royalty-driven business model, partnering with other biopharmaceutical companies to finance and advance late-stage clinical programs while also managing a broad portfolio of royalty interests. Its current portfolio spans commercial, clinical, and preclinical-stage assets across multiple therapeutic areas, including infectious diseases, oncology, respiratory conditions, kidney disease, and rare diseases. The company also works through technology licensing and asset acquisition activities to expand the range of medicines connected to its platform. Based in Jupiter, Florida, Ligand Pharmaceuticals Incorporated plays a specialized role in the life sciences market by providing capital, expertise, and royalty management across a diversified set of partnered drug programs.
Website555 Heritage Drive
Jupiter, FL, 33458
United States
The latest articles about LGND.
Tipranks Press Release.
Investors seeking a high yield and stable fundamentals in the healthcare sector need look no further than Bristol Myers Squibb.
Summary of Apr 27's posts. Generated by AI.
Summary of Feb 10's posts. Generated by AI.
Wall Street analysts react to the outcome of SpaceX's Starship flight 14 mission on Monday, eye potential for future launches.
Summary of Apr 27's posts. Generated by AI.
Summary of Apr 27's posts. Generated by AI.
Investors talking about LGND also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.